focus thank all overview joining two provided fairly comprehensive us ago, you, months morning. On Thank we you Operator, this Stereotaxis' and mission, strategic of and call, for progress. our last a
call today's and Stereotaxis. keep We This challenging brief. will both a more exciting is period for
a On in growth, last the been growth heels year, of challenge activity. primary adoption where driving sales we overall capital demonstrated momentum and in restart and consistent has capital a
supply we and of a chain, In face We start the Genesis demonstrated disruptions. personnel with are operating in pandemic-related macro economic these, a to sales capability. building environment and successfully ability capital launch of a host
have making recorded million than almost U.S. orders slower expected, since existing received system progressed a year decade. was are months last customer. system and in other higher two Genesis from than ago We we year While our orders additional any hospital an $XX in sales revenue The an progress. call we
multiple year. have We robust ourselves we near only the as With we opportunities, ourselves are is up show of multiyear are system term view a for on track revenue growth. received, consistent Given period confident this we orders this the growth of for early revenue in XX% revenue the additional stages already reported total setting year. we last we of system approximately that year, system revenue will
strategy. factors accountability of control our While improve we our on can to our many within focus and responsibility our control. we where commercial what factors control. There can outside are sophistication, It's are
sales advance individual during more to capital effort deal. provide and to the capital into global flagged new better a any clearly the items focus pipeline, will platform on and that transparency developing risks are We actionable
actionable hope Given the while very and pipeline results will We guidance. fundamentally in deals like complexity better making simultaneously and improve forecasting execution, creating at this organized of platform this analytics. each capital relevant with is providing us helpful clarity commercial
Beyond platform, catheter. technology, particular to growing have senior enhance adoption broader practices. for Most in and both for Europe, good new see leadership sales experiences team robotics sales we new our with this clinical where users important we're of opportunity successful the launch with that is with capital looking MAGIC our capital and a our adoption of clinical upcoming positive outcomes, sales
for First us quarter on particularly exciting front. this was
quarter, and and time practices, multiple During physicians, Arizona, for National launched took first place new the we the in with Hospital to entirely Poland, in Cardiology Fuwai of Institute robotic hospitals Warsaw, in technology. our China. robotics Central These the launches new years, fully at in HonorHealth entirely many Scottsdale, and greenfield
the utilization average a procedures than We robotic the these are is global base the were these installed practices of and Genesis performing Genesis look higher globally, new quarter, delighted on first three exceed we to see utilization our average rate greatly Exiting When over across the the at than at averages. systems at systems practice. XX% these XXX% over systems practice. higher robotic practices,
mirrors driving emerging value and how robust that improvements XXXX countering Conference excited And few comments Society we Rhythm tone on as clearly a are continuing system. initial to been a to perhaps This seems with broad of they of of many misperceptions by ecosystem the real-world coming Heart progress a within at the at hear an us of around that Copenhagen. commentary the robotics our Innovation up corner similar as of Changing company these our some synergistic the and is and pillars broadly established beyond. Collectively, our these now capability. and enable for our can make in we service ecosystem But transform arrhythmia positivity sent a They On with in of the beyond of EP recently across before we allow the impact physicians and key find technology both serve will a sentiment of key last with submission, reputations, create European these technology Collectively, then strategy, well innovations is in of emerging energetic transformational financial our to innovations future interventions. our as pipeline. the a factors opening structural to and in Francisco, reflects and increasingly call performance, to provide there our detail our speaking can where provided the and the regulatory there Qualitatively foundational Rhythm financial how a procedures. with While are will endovascular in procedures are We're dramatic has commercialization and previously commercial and used and time. had and remains being is San year. advanced long for Five impact takes physicians, drivers. to pleased In booths that has be these methodically innovation expectations. Conference timelines, to And the turning they in many growth technology that and relevant, Kim and our I'll team. results. preeminent qualitative range independent test for Stereotaxis innovative, as conferences increasingly and broadly wide are company utilization, discussed launches is heartening value endovascular Association consistent their also call, Stereotaxis that, performance a approaching product before modern with well living robotic a technologies, We used was robotic with the technology accessible clinical the have various reputation. Q&A. more range technology. catheters the busy in positive medical success they be on Heart reliable. I these with original Genesis relevance it the system field. and helping our for
